The genetic test does not predict whether you will experience hiccups or nausearather, it reveals predispositions in the GLP-1 receptor and metabolic pathways
They named it a triple agonist because it targets GLP-1, GIP, and glucagon receptors
Glucagon-Like Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly
However, the FDA recently recategorized GHRP-2 as a significant risk (11)
Great Works great as a maintenance dose
As part of a multicenter, long-term (6 months), double-blind, placebo-controlled randomized clinical trial of 82 maintenance hemodialysis patients (see below), 272 Holter monitoring was performed during a single dialysis period during the baseline (nontreatment) period, during the treatment period, and at the end of the treatment phase